New pill formula tested in patients with schizophrenia or bipolar disorder
NCT ID NCT06494397
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 27 times
Summary
This study tested whether a new tablet (VHX-896) works the same as the approved drug iloperidone in 26 adults with schizophrenia or bipolar I disorder. Participants took both versions under steady conditions to compare drug levels and side effects. The goal was to see if the new formulation is a safe and effective alternative for ongoing disease management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanda Investigational Site
Los Alamitos, California, 90720, United States
-
Vanda Investigational Site
Gaithersburg, Maryland, 20877, United States
-
Vanda Investigational Site
Marlton, New Jersey, 08053, United States
Conditions
Explore the condition pages connected to this study.